Similar articles

• Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.

  Neben S, Hellman S, Montgomery M, Ferrara J, Mauch P. Neben S, et al. Exp Hematol. 1993 Jan;21(1):156-62. Exp Hematol. 1993. PMID: 8435103
• Pharmacology of agents used in bone marrow transplant conditioning regimens.

  Wiebe VJ, Smith BR, DeGregorio MW, Rappeport JM. Wiebe VJ, et al. Crit Rev Oncol Hematol. 1992 Nov;13(3):241-70. doi: 10.1016/1040-8428(92)90092-5. Crit Rev Oncol Hematol. 1992. PMID: 1476655 Review. No abstract available.
• Effect of myleran on murine hemopoiesis. II. Direct and host-mediated action on proliferative capacity and differentiation bias of spleen colony forming units (CFU-S).

  Delmonte L. Delmonte L. Cell Tissue Kinet. 1978 Jul;11(4):359-67. Cell Tissue Kinet. 1978. PMID: 688327 No abstract available.
• [The role of the hemopoiesis-inducing microenvironment in the mechanisms of the regeneration of hemopoiesis after cytostatic exposure].

  Dygaĭ AM, Zhadanov VV, Bogdashin IV, Gol'dberg VE. Dygaĭ AM, et al. Nauchnye Doki Vyss Shkoly Biol Nauki. 1992;(9):109-16. Nauchnye Doki Vyss Shkoly Biol Nauki. 1992. PMID: 1302526 Russian.
• The problem of permanent bone marrow damage after cytotoxic drug treatment.

  Lohrmann HP. Lohrmann HP. Oncology. 1984;41(3):180-4. doi: 10.1159/000225819. Oncology. 1984. PMID: 6374556 Review.